This content is machine translated New oral anticoagulants 10 questions from daily use The new oral anticoagulants (NOAKs) have long since become part of everyday clinical practice in stroke prophylaxis for atrial fibrillation. Due to their simpler, safer, and effective use, they are…
View Post 6 min This content is machine translated Stroke prevention in VHF Real-life data with dabigatran convincing For the first time, real-life data are available for one of the new oral anticoagulants. These were presented in Zurich on October 2, 2013. They demonstrate a compelling safety and…
View Post 6 min This content is machine translated Current overview New Anticoagulants in Prevention and Therapy of Thromboembolism The standard treatment for acute venous thromboembolism currently includes parenteral heparin administration, overlapping with the administration of a vitamin K antagonist (VKA). New oral anticoagulants (NOACs) and VKAs show different…
View Post 2 min This content is machine translated Stroke prevention in atrial fibrillation Dabigatran exilate for effective prevention of patients with atrial fibrillation. For the first time, long-term study data show that dabigatran etexilate is an effective and safe therapeutic option in the prevention of stroke in patients with atrial fibrillation among novel…
